Modification of the number and phenotype of striatal dopaminergic cells by carotid body graft

Brain

Volumn 130, Issue 5, 2007, Pages 1306-1316

  San Sebastian W ^a   Guillen J ^a   Manrique, M ^a,b   Belzunegui, S ^a   Ciordia, E ^a   Izal Azccrate A ^a   Garrido Gil, P ^a   Vazquez Claverie M ^a   Luquin, M R ^a,b  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

Carotid body graft; Dopaminergic cells; Macaca fascicularis; Parkinson's disease; Striatum

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; AROMATIC LEVO AMINO ACID DECARBOXYLASE; CALBINDIN; CALRETININ; DOPAMINE; DOPAMINE TRANSPORTER; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLUTAMATE DECARBOXYLASE; NEURONAL NITRIC OXIDE SYNTHASE; PARVALBUMIN; TYROSINE 3 MONOOXYGENASE; VESICULAR MONOAMINE TRANSPORTER 2; BIOLOGICAL MARKER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; CAROTID BODY; CELL AGGREGATION; CELL COUNT; CELL DENSITY; CELL SUBPOPULATION; CELL TRANSPLANTATION; COMPARATIVE STUDY; CONTROLLED STUDY; CORPUS STRIATUM; DISABILITY; DOPAMINE METABOLISM; DOPAMINERGIC NERVE CELL; INTERNEURON; MONKEY; MOUSE; NEUROCHEMISTRY; NONHUMAN; PARKINSONISM; PHENOTYPE; PRIMATE; PRIORITY JOURNAL; RAT; RATING SCALE; SPECIES COMPARISON; STATISTICAL SIGNIFICANCE; TISSUE GRAFT; TISSUE SECTION; ANIMAL; CELL DIFFERENTIATION; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOHISTOCHEMISTRY; MACACA; METABOLISM; PATHOLOGY; TRANSPLANTATION;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; BIOLOGICAL MARKERS; CAROTID BODY; CELL COUNT; CELL DIFFERENTIATION; CORPUS STRIATUM; DOPAMINE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; IMMUNOHISTOCHEMISTRY; MACACA FASCICULARIS; MODELS, ANIMAL; PARKINSONIAN DISORDERS; TYROSINE 3-MONOOXYGENASE;

EID: 34249683719     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awm061     Document Type: Article

References (54)

1. Airaksinen MS, Saarma M. The GDNF family: signalling, biological functions and therapeutic value. Nat Rev Neurosci 2002; 3: 383-94.
2. Arjona V, Minguez-Castellanos A, Montoro RJ, Ortega A, Escamilla F, Toledo-Aral JJ, et al. Autotransplantation of human carotid body cell aggregates for treatment of Parkinson's disease. Neurosurgery 2003; 53: 321-8; discussion 328-30.
3. Baker H, Kobayashi K, Okano H, Saino-Saito S. Cortical and striatal expression of tyrosine hydroxylase mRNA in neonatal and adult mice. Cell Mol Neurobiol 2003; 23: 507-18.
4. Bankiewicz KS, Oldfield EH, Chiueh CC, Doppman JL, Jacobowitz DM, Kopin IJ. Hemiparkinsonism in monkeys after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Life Sci 1986; 39: 7-16.
5. Bedard A, Cossette M, Levesque M, Parent A. Proliferating cells can differentiate into neurons in the striatum of normal adult monkey. Neurosci Lett 2002; 328: 213-6.
6. Betarbet R, Turner R, Chockkan V, DeLong MR, Allers KA, Walters J, et al. Dopaminergic neurons intrinsic to the primate striatum. J Neurosci 1997; 17: 6761-8.
7. Bjorklund A, Kirik D, Rosenblad C, Georgievska B, Lundberg C, Mandel RJ. Towards a neuroprotective gene therapy for Parkinson's disease: use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model. Brain Res 2000; 886: 82-98.
8. Cao X, Sun S, Liu H, Tong E, Xia H. Dynamic expression of bFGF and TGFbeta2 in glomus cell grafts of carotid body in rat model of Parkinson disease. J Huazhong Univ Sci Technolog Med Sci 2003; 23: 380-2, 395.
9. Cossette M, Bedard A, Parent A. Dopaminergic neurons in human striatum and neurogenesis in adult monkey. Ann NY Acad Sci 2003; 991: 346-9.
10. Cossette M, Lecomte F, Parent A. Morphology and distribution of dopaminergic neurons intrinsic to the human striatum. J Chem Neuroanat 2005a; 29: 1-11.
11. Cossette M, Levesque D, Parent A. Neurochemical characterization of dopaminergic neurons in human striatum. Parkinsonism Relat Disord 2005b; 11: 277-86.
12. Cossette M, Levesque M, Parent A. Extrastriatal dopaminergic innervation of human basal ganglia. Neurosci Res 1999; 34: 51-4.
13. Di Giulio C, Bianchi G, Cacchio M, Artese L, Rapino C, Macri MA, et al. Oxygen and life span: chronic hypoxia as a model for studying HIF-1alpha, VEGF and NOS during aging. Respir Physiol Neurobiol 2005; 147: 31-8.
14. Dubach M, Schmidt R, Kunkel D, Bowden DM, Martin R, German DC. Primate neostriatal neurons containing tyrosine hydroxylase: immunohistochemical evidence. Neurosci Lett 1987; 75: 205-10.
15. Espejo EF, Montoro RJ, Armengol JA, Lopez-Barneo J. Cellular and functional recovery of Parkinsonian rats after intrastriatal transplantation of carotid body cell aggregates. Neuron 1998; 20: 197-206.
16. Freed CR, Greene PE, Breeze RE, Tsai WY, DuMouchel W, Kao R, et al. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med 2001; 344: 710-9.
17. Garris PA, Ciolkowski EL, Pastore P, Wightman RM. Efflux of dopamine from the synaptic cleft in the nucleus accumbens of the rat brain. J Neurosci 1994; 14: 6084-93.
18. Gash DM, Zhang Z, Ai Y, Grondin R, Coffey R, Gerhardt GA. Trophic factor distribution predicts functional recovery in parkinsonian monkeys. Ann Neurol 2005; 58: 224-33.
19. Graveland GA, DiFiglia M. The frequency and distribution of medium-sized neurons with indented nuclei in the primate and rodent neostriatum. Brain Res 1985; 327: 307-11.
20. Hao G, Yao Y, Wang J, Zhang L, Viroonchatapan N, Wang ZZ. Intrastriatal grafting of glomus cells ameliorates behavioral defects of Parkinsonian rats. Physiol Behav 2002; 77: 519-25.
21. Horn AS. Dopamine uptake: a review of progress in the last decade. Prog Neurobiol 1990; 34: 387-400.
22. Huot P, Levesque M, Parent A. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea. Brain 2007; 130: 222-32.
23. Jollivet C, Montero-Menei CN, Venier-Julienne MC, Sapin A, Benoit JP, Menei P. Striatal tyrosine hydroxylase immunoreactive neurons are induced by L-dihydroxyphenylalanine and nerve growth factor treatment in 6-hydroxydopamine lesioned rats. Neurosci Lett 2004; 362: 79-82.
24. Kawaguchi Y, Wilson CJ, Augood SJ, Emson PC. Striatal interneurones: chemical, physiological and morphological characterization. Trends Neurosci 1995; 18: 527-35.
25. Kishima H, Poyot T, Bloch J, Dauguet J, Conde F, Dolle F, et al. Encapsulated GDNF-producing C2C12 cells for Parkinson's disease: a pre-clinical study in chronic MPTP-treated baboons. Neurobiol Dis 2004; 16: 428-39.
26. Krieglstein K. Factors promoting survival of mesencephalic dopaminergic neurons. Cell Tissue Res 2004; 318: 73-80.
27. Lin LF, Doherty DH, Lile JD, Bektesh S, Collins F. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 1993; 260: 1130-2.
28. Lopez-Real A, Rodriguez-Pallares J, Guerra MJ, Labandeira-Garcia JL. Localization and functional significance of striatal neurons immunoreactive to aromatic L-amino acid decarboxylase or tyrosine hydroxylase in rat Parkinsonian models. Brain Res 2003; 969: 135-46.
29. Luquin MR, Montoro RJ, Guillen J, Saldise L, Insausti R, Del Rio J, et al. Recovery of chronic parkinsonian monkeys by autotransplants of carotid body cell aggregates into putamen. Neuron 1999; 22: 743-50.
30. Mazloom M, Smith Y. Synaptic microcircuitry of tyrosine hydroxylase-containing neurons and terminals in the striatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys. J Comp Neurol 2006; 495: 453-69.
31. Meredith GE, Farrell T, Kellaghan P, Tan Y, Zahm DS, Totterdell S. Immunocytochemical characterization of catecholaminergic neurons in the rat striatum following dopamine-depleting lesions. Eur J Neurosci 1999; 11: 3585-96.
32. Mura A, Jackson D, Manley MS, Young SJ, Groves PM. Aromatic L-amino acid decarboxylase immunoreactive cells in the rat striatum: a possible site for the conversion of exogenous L-DOPA to dopamine. Brain Res 1995; 704: 51-60.
33. Nosrat CA, Tomac A, Lindqvist E, Lindskog S, Humpel C, Stromberg I, et al. Cellular expression of GDNF mRNA suggests multiple functions inside and outside the nervous system. Cell Tissue Res 1996; 286: 191-207.
34. Olanow CW, Goetz CG, Kordower JH, Stoessl AJ, Sossi V, Brin MF, et al. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann Neurol 2003; 54: 403-14.
35. Paciga M, Nurse CA. Basic FGF localization in rat carotid body: paracrine role in O2-chemoreceptor survival. Neuroreport 2001; 12: 3287-91.
36. Palfi S, Leventhal L, Chu Y, Ma SY, Emborg M, Bakay R, et al. Lentivirally delivered glial cell line-derived neurotrophic factor increases the number of striatal dopaminergic neurons in primate models of nigrostriatal degeneration. J Neurosci 2002; 22: 4942-54.
37. Patel NK, Bunnage M, Plaha P, Svendsen CN, Heywood P, Gill SS. Intraputamenal infusion of glial cell line-derived neurotrophic factor in PD: a two-year outcome study. Ann Neurol 2005; 57: 298-302.
38. Pencea V, Bingaman KD, Wiegand SJ, Luskin MB. Infusion of brain-derived neurotrophic factor into the lateral ventricle of the adult rat leads to new neurons in the parenchyma of the striatum, septum, thalamus, and hypothalamus. J Neurosci 2001; 21: 6706-17.
39. Porritt MJ, Batchelor PE, Hughes AJ, Kalnins R, Donnan GA, Howells DW. New dopaminergic neurons in Parkinson's disease striatum. Lancet 2000; 356: 44-5.
40. Prensa L, Cossette M, Parent A. Dopaminergic innervation of human basal ganglia. J Chem Neuroanat 2000; 20: 207-13.
41. Reynolds BA, Weiss S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 1992; 255: 1707-10.
42. Rose S, Nomoto M, Kelly E, Kilpatrick G, Jenner P, Marsden CD. Increased caudate dopamine turnover may contribute to the recovery of motor function in marmosets treated with the dopaminergic neurotoxin MPTP. Neurosci Lett 1989; 101: 305-10.
43. Shukla S, Agrawal AK, Chaturvedi RK, Seth K, Srivastava N, Sinha C, et al. Co-transplantation of carotid body and ventral mesencephalic cells as an alternative approach towards functional restoration in 6-hydroxydopamine- lesioned rats: implications for Parkinson's disease. J Neurochem 2004; 91: 274-84.
44. Slevin JT, Gash DM, Smith CD, Gerhardt GA, Kryscio R, Chebrolu H, et al. Unilateral intraputaminal glial cell line-derived neurotrophic factor in patients with Parkinson disease: response to 1 year each of treatment and withdrawal. Neurosurg Focus 2006; 20: E1.
45. Smith Y, Kieval JZ. Anatomy of the dopamine system in the basal ganglia. Trends Neurosci 2000; 23: S28-33.
46. Szabo J, Cowan WM. A stereotaxic atlas of the brain of the cynomolgus monkey (Macaca fascicularis). J Comp Neurol 1984; 222: 265-300.
47. Tande D, Hoglinger G, Debeir T, Freundlieb N, Hirsch EC, Francois C. New striatal dopamine neurons in MPTP-treated macaques result from a phenotypic shift and not neurogenesis. Brain 2006; 129: 1194-200.
48. Tashiro Y, Kaneko T, Sugimoto T, Nagatsu I, Kikuchi H, Mizuno N. Striatal neurons with aromatic L-amino acid decarboxylase-like immunoreactivity in the rat. Neurosci Lett 1989a; 100: 29-34.
49. Tashiro Y, Sugimoto T, Hattori T, Uemura Y, Nagatsu I, Kikuchi H, et al. Tyrosine hydroxylase-like immunoreactive neurons in the striatum of the rat. Neurosci Lett 1989b; 97: 6-10.
50. Toledo-Aral JJ, Mendez-Ferrer S, Pardal R, Lopez-Barneo J. Dopaminergic cells of the carotid body: physiological significance and possible therapeutic applications in Parkinson's disease. Brain Res Bull 2002; 57: 847-53.
51. Villadiego J, Mendez-Ferrer S, Valdes-Sanchez T, Silos-Santiago I, Farinas I, Lopez-Barneo J, et al. Selective glial cell line-derived neurotrophic factor production in adult dopaminergic carotid body cells in situ and after intrastriatal transplantation. J Neurosci 2005; 25: 4091-8.
52. Wang ZY, Bisgard GE. Postnatal growth of the carotid body. Respir Physiol Neurobiol 2005; 149: 181-90.
53. Weihe E, Depboylu C, Schutz B, Schafer MK, Eiden LE. Three types of tyrosine hydroxylase-positive CNS neurons distinguished by dopa decarboxylase and VMAT2 co-expression. Cell Mol Neurobiol 2006.
54. Wu Y, Parent A. Striatal interneurons expressing calretinin, parvalbumin or NADPH-diaphorase: a comparative study in the rat, monkey and human. Brain Res 2000; 863: 182-91.